{"nct_id":"NCT01275196","title":"Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients","status":"COMPLETED","status_verified_date":"2016-03","start_date":"2011-04","start_date_type":null,"primary_completion_date":"2014-10","primary_completion_date_type":"ACTUAL","completion_date":"2014-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}